In focus
Latest feed
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Nektar Therapeutics Charts a Course Forward: Q2 2026 Sees Strategic Investment Amidst Financial Shifts
The Great Biotech Bet: Prediction Markets Clash with Medical Ethics
